Výsledky vyhledávání - "C. Raveau-Landon"

Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007

Autor: M. Rothman, Steen Dalby Kristensen, C. Isaia, Eugene Braunwald, William Wijns, D. Allocco, M. Pfisterer, M. Waliszewski, Martin T. Rothman, Maarten L. Simoons, S. Carlier, Adrian Bagust, Lars Wallentin, L. Wallentin, Philippe Gabriel Steg, P.G. Steg, P. de Jong, S. Ternstrom, H. Dobbels, C. DiMario, Hans L. Hillege, S. Kloth, G. Guagliumi, A. Patteet, Patrick W. Serruys, W. Wijns, Carlo DiMario, Matthias Pfisterer, Joost Daemen, A. Aimonetti, H.L. Hillege, A. Gitt, P. Jüni, M. Berenger, Jean Fajadet, G. Bos, A. Baczynska, Victor Legrand, J. Daemen, E. Camenzind, A. Kastrati, A. Potgieter, Sabine Kloth, E. Klasen, Ibrahim Tariah, S. James, S. Hellbardt, Bernard Chevalier, I. Tariah, Stefan James, H. Nagai, Sigmund Silber, J.C. Ghislain, F. Ni Mhullain, Anselm K. Gitt, Gert Bos, P. W. Serruys, Giulio Guagliumi, J. Fajadet, C. Raveau-Landon, R. ten Hoedt, Adnan Kastrati, Mitchell W. Krucoff, B. Chevalier, J. Van Wuytswinkel, Andrew Farb, E Braunwald, A. Bagust, Peter Jüni, S. Silber, A. Boam, M.W. Krucoff, J.P. Calle, James M. Bowen, G. Campo, V. Legrand, J.M. Bowen, G. Di Bisceglie, I. Purdy, M. Lekehal, S Windecker, D. Paunovic, M. L. Simoons, Stephan Windecker, J. de Schepper, L. LeNarz, Edoardo Camenzind

Publikováno v: European Heart Journal. 30:152-161

Drug-eluting stents (DES) were introduced into clinical practice in 2002 in order to reduce restenosis that occurred in 15–25% of patients receiving bare-metal stents (BMS).1–3 Subsequent trials with different types of DES confirmed their efficac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe0c227e05a5542f3e68a6cc116b4978
https://doi.org/10.1093/eurheartj/ehn510

Zobrazit plný text záznamu

Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007

Autor: Joost, Daemen, Maarten L, Simoons, William, Wijns, Adrian, Bagust, Gert, Bos, James M, Bowen, Eugene, Braunwald, Edoardo, Camenzind, Bernard, Chevaliers, Carlo, DiMario, Jean, Fajadeto, Anselm, Gitt, Giulio, Guagliumi, Hans L, Hillege, Stefan, James, Peter, Jüni, Adnan, Kastrati, Sabine, Kloth, Steen D, Kristensen, Mitchell, Krucoff, Victor, Legrand, Matthias, Pfisterer, Martin, Rothman, Patrick W, Serruys, Sigmund, Silber, Philippe G, Steg, Ibrahim, Tariah, Lars, Wallentin, Stephan W, Windecker, A, Aimonetti, D, Allocco, M, Berenger, A, Boam, J P, Calle, G, Campo, S, Carlier, J, de Schepper, G, Di Bisceglie, H, Dobbels, A, Farb, J C, Ghislain, S, Hellbardt, R, ten Hoedt, C, Isaia, P, de Jong, M, Lekehal, L, LeNarz, F Ni, Mhullain, H, Nagai, A, Patteet, D, Paunovic, A, Potgieter, I, Purdy, C, Raveau-Landon, S, Ternstrom, J, Van Wuytswinkel, M, Waliszewski

Publikováno v: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 4(4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::494e227577d9f38017236cda126ffcff
https://pubmed.ncbi.nlm.nih.gov/19284062

Zobrazit plný text záznamu

[Short and long-term clinical tolerance of hypertensive treatment during the HOT study (Hypertension Optimal Treatment)]

Autor: J M, Mallion, N G, Pehrsson, C, Raveau-Landon, S, Boutelant, J, Ménard

Publikováno v: Archives des maladies du coeur et des vaisseaux. 89(8)

International, prospective, randomized HOT study aims to determine the optimal BP level under treatment in order to reduce at the most the cardiovascular morbidity/mortality. Defined by randomization, the level to obtain is DBPor = 80, 85, 90 mmHg. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0d07866c0578f4ca465eb7817735b4e5
https://pubmed.ncbi.nlm.nih.gov/8949385

Zobrazit plný text záznamu

VALIDATION OF BLOOD PRESSURE MEASURING DEVICES IN FRANCE

Autor: B. Vaisse, Roland Asmar, C. Raveau-Landon, Guillaume Bobrie

Publikováno v: Journal of Hypertension. 22:S306

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b7d22f5aec700e65fe4286ac7814ce1
https://doi.org/10.1097/00004872-200406002-01058

Zobrazit plný text záznamu

Clinical tolerance of short- and long-term antihypertensive treatment during the HOT study

Autor: C Raveau-Landon, S Boutelant, N Gunnar Pehrsson, J. M. Mallion, J Ménard

Publikováno v: Journal of Hypertension. 15:699

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::04f77ddb9ada9a78de5f36c74eab5846
https://doi.org/10.1097/00004872-199715060-00038

Zobrazit plný text záznamu

[Treatment of essential hypertension with felodipine or atenolol as first line therapy. Comparative double-blind randomized study]

Autor: J P, Lesbre, S, Witchitz, M, Andrejak, P, Morand, C, Raveau-Landon

Publikováno v: Presse medicale (Paris, France : 1983). 18(3)

This study involved 113 patients (mean age 50 +/- 14 years) with diastolic blood pressure above 95 mmHg. The patients abstained from taking any antihypertensive drug and received a placebo for one week before entering felodipine, a new calcium antago

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::415c0d6490c5a9793cca0262103f3fb6
https://pubmed.ncbi.nlm.nih.gov/2521934

Zobrazit plný text záznamu

[Metoprolol, a new effective antimigraine agent]

Autor: C, Raveau-Landon, M G, Bousser

Publikováno v: Presse medicale (Paris, France : 1983). 17(35)

The effectiveness of metoprolol as a prophylactic treatment of migraine was investigated in double-blind comparative trials involving more than 500 patients. In two trials using a slow-release preparation and a dose of 200 mg per day, metoprolol prov

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6313e64a07bf8da04317bbe30337b994
https://pubmed.ncbi.nlm.nih.gov/2978324

Zobrazit plný text záznamu

[Felodipine in arterial hypertension. Double-blind comparison with atenolol]

Autor: M, Andrejak, S, Witchitz, P, Morand, J P, Lesbre, C, Raveau-Landon

Publikováno v: Therapie. 44(3)

Felodipine is a new dihydropyridine calcium antagonist which selectively relaxes vascular smooth muscle. It lovers dose-dependently blood pressure in hypertensives patients. In this multicentre double-blind study, 113 patients (mean age 50 +/- 14 yea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8b4ebc97d761c9cc0db51024ea334a1f
https://pubmed.ncbi.nlm.nih.gov/2675377

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání